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Abstract
Background: Blastocystis spp. are the most prevalent intestinal eukaryotes identified in humans, with at least 17
genetic subtypes (ST) based on genes coding for the small-subunit ribosomal RNA (18S). It has been argued that the 18S
gene should not be the marker of choice to discriminate between STs of these strains because this marker exhibits high
intra-genomic polymorphism. By contrast, pyruvate:ferredoxin oxidoreductase (PFOR) is a relevant enzyme involved in the
core energy metabolism of many anaerobic microorganisms such as Blastocystis, which, in other protozoa, shows more
polymorphisms than the 18S gene and thus may offer finer discrimination when trying to identify Blastocystis ST.
Therefore, the objective of the present study was to assess the suitability of the PFOR gene as an additional marker to
discriminate among Blastocystis strains or subtypes from symptomatic carrier children.
Methods: Faecal samples from 192 children with gastrointestinal symptoms from the State of Mexico were submitted for
coprological study. Twenty-one of these samples were positive only for Blastocystis spp.; these samples were analysed by
PCR sequencing of regions of the 18S and PFOR genes. The amplicons were purified and sequenced; afterwards, both
markers were assessed for genetic diversity.
Results: The 18S analysis showed the following frequencies of Blastocystis subtypes: ST3 = 43%; ST1 = 38%; ST2 = 14%;
and ST7 = 5%. Additionally, using subtype-specific primer sets, two samples showed mixed Blastocystis ST1 and ST2
infection. For PFOR, Bayesian inference revealed the presence of three clades (I-III); two of them grouped different ST
samples, and one grouped six samples of ST3 (III). Nucleotide diversity (π) and haplotype polymorphism (θ) for the 18S
analysis were similar for ST1 and ST2 (π = ~0.025 and θ = ~0.036); remarkably, ST3 showed almost 10-fold lower values.
For PFOR, a similar trend was found: clade I and II had π = ~0.05 and θ = ~0.05, whereas for clade III, the values were
almost 6-fold lower.
Conclusions: Although the fragment of the PFOR gene analysed in the present study did not allow discrimination
between Blastocystis STs, this marker grouped the samples in three clades with strengthened support, suggesting that
PFOR may be under different selective pressures and evolutionary histories than the 18S gene. Interestingly, the ST3
sequences showed lower variability with probable purifying selection in both markers, meaning that evolutionary
forces drive differential processes among Blastocystis STs.
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Background
Blastocystis spp. are the most prevalent intestinal eu-
karyotes identified in humans and are one of the two
known stramenopiles that can infect humans [1–4]. Low
host specificity and extensive morphological and genetic
diversity have been documented in this genus [4, 5].
Four stages or morphotypes are presently recognized in
Blastocystis: vacuolar, also named “central body”, granu-
lar, amoeboid and cyst. Furthermore, 17 ribosomal line-
ages, known as subtypes (ST), have been described
based on genotyping of the small-subunit ribosomal
RNA (18S). ST1-ST9 are found in humans; however,
they have also been reported in other hosts [5–8]. Some
epidemiological and molecular data support a potential
pathogenic role for these microorganisms [9–11]. How-
ever, the clinical relevance of Blastocystis is still contro-
versial [12, 13]. Previous studies suggest that due to the
exceptional inter- and intra-subtype genetic variability, it
is not possible to establish, without doubt, the patho-
genic role of Blastocystis because pathogenesis may be
subtype-dependent [14, 15].
Recently, some factors known as “moonlighting pro-
teins” were shown to be capable of enhancing virulence
in eukaryotic pathogens; these proteins are enzymes with
key metabolic functions in glycolysis, the pentose phos-
phate cycle or other fundamental intracellular processes.
These proteins may perform non-catalytic roles with dif-
ferent functions depending on their cellular localization
and the concentration of substrates or additional ligands.
This group of proteins includes the pyruvate:ferredoxin
oxidoreductase enzyme (PFOR) [16, 17].
PFOR is a Fe-S enzyme that uses thiamine pyrophosphate
(TPP) and magnesium (Mg+2) as cofactors. It is involved in
the energy metabolism of many anaerobic organisms and
allows energy conservation by substrate-level phosphoryl-
ation with reversible catalysis of the oxidative decarboxyl-
ation of pyruvate to Acetyl-CoA and CO2. The resulting
electrons are transferred to a low-redox potential, which
depending on the physiological electron acceptor may in-
volve hydrogen or activate molecules [18–20].
PFOR was initially identified in Clostridium acidi-urici
[21], but the first description of its enzyme activity in
eukaryotes was in Entamoeba histolytica [22]. It was
subsequently described in other anaerobic parasites such
as Trichomonas vaginalis [23], Giardia lamblia [24] and
Blastocystis spp. [25]. In vivo and in vitro studies of the
role of PFOR expression in parasites have suggested that
it could be involved in cytoadherence, in the prolifera-
tion of trophozoites, and, under specific conditions, in
the formation of subcutaneous abscesses [26]. Therefore,
the purpose of this study was to assess the suitability of
using the PFOR gene as an additional marker to discrim-
inate among Blastocystis strains or subtypes from
symptomatic carrier children.
Methods
Faecal samples from 192 children who attended medical
consultation for gastrointestinal disorders at the Hospital
para el Niño del Instituto Materno Infantil from the
State of Mexico (IMIEM) between January and June
2017 were analysed by coprological methods. Faust’s
technique and microscopic observation were used to
search for parasitic structures and to define the parasitic
load per field using the 40× objective.
Approximately 50 mg of faeces from each participant
was cultured in 7 ml of Boeck-Drbohlav modified
medium at 37 °C for 3 days [27]. The concentration of
Blastocystis cells was measured in a Neubauer chamber
at 0 h, 48 h and 72 h. Additionally, an aliquot of up to
200 μl containing Blastocystis cells was used to extract
DNA using a ZR Fecal DNA MiniPrepTM kit (Zymo
Research, Irvine, CA, USA) according to the manufac-
turer’s protocol; the DNA concentration was determined
by UV spectrophotometry, and DNA aliquots were
stored at -20 °C until molecular analysis.
Subtype identification was performed according to
Santin et al. [28]. To establish mixed infections between
Blastocystis ST1, ST2 and ST3, ST-specific primers from
previous reports were used [10, 11, 29–33]. To analyse
the PFOR gene, specific primers for Blastocystis were
designed based on available sequences in the GenBank
database (ST7, XM_013038360; ST7, XM_013042447;
ST4, XM_014671717; ST4, XM_014673113; ST7, XM_
013039547; ST7, XM 013041057; ST7, XM_013038149;
ST7, XM_013041791; and NandII ST1, EF512300). A suit-
able region of ~871 bp was chosen for amplification by
the primers BlasPFOR-F: 5'-TGG CGA ACG CGA TGG
GCT GCT CG-3' and BlasPFOR-R: 5'-CCA GCT GGA
ACG GGT TCT CGC CC-3'.
The PCR mixture contained 25 pmol/μl each primer,
200 ng/μl genomic DNA, 2 mM MgCl2, 1× PCR buffer
(200 mM Tris-HCl, pH 8.4, 500 mM KCl), 0.2 mM
dNTPs, 0.01 mg of BSA and 1 U of Taq DNA polymer-
ase (Invitrogen, Carlsbad, CA, USA); concentration of
reagents was calculated and adjusted for 25 μl volume
reaction.
A total of 40 cycles, each consisting of 94 °C for 30 s, 69
°C for 90 s and 72 °C for 60 s, was performed; an initial
pre-heat step at 94 °C for 5 min and a final extension step
at 72 °C for 7 min were also included. The PCR products
were separated by 1.2% agarose gel electrophoresis,
visualized by ethidium bromide staining (0.5 μg/ml)
and purified with an illustraTM GFXTM PCR DNA
and Gel Band Purification kit (GE Healthcare, Little
Chalfont, Buckinghamshire, UK). The purified prod-
ucts were sequenced in both directions at the Insti-
tuto de Biologia, Universidad Nacional Autonoma de
Mexico. DNA of the Blastocystis strain ATCC-50754
(ST3) was used as a positive control.
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All sequences were subjected to BLAST searches in
the GenBank database to confirm they were from Blas-
tocystis spp. specimens. Sequences for both genes ob-
tained in this study were aligned with those available in
public databases using the Clustal W and Muscle
algorithms included in MEGA software version 7.0.26
[34–36]. Phylogenetic reconstruction was conducted
using a Bayesian approach with MrBayes version 3.2
[37]. The analysis was performed for 10,000,000 genera-
tions with sampling trees every 100 generations. Trees
with scores lower than those at the stationary phase
(‘burn-in’) were discarded, and trees that reached the
stationary phase were collected and used to build major-
ity consensus trees. Other sequences of 18S from differ-
ent Blastocystis STs and PFOR from other pathogens
(such as Entamoeba spp. and Trichomonas vaginalis)
were obtained from GenBank and used as references.
Genetic diversity indices for both the 18S and PFOR
sequences were obtained with DnaSPv6 software [38]
and included nucleotide diversity (π, the average propor-
tion of nucleotide differences between all possible pairs
of sequences in the sample) and haplotype polymorph-
ism (θ, the proportion of nucleotide sites that are ex-
pected to be polymorphic in any suitable sample from
this region of the genome). These indices range in value
from 0 to 1 and are used to assess polymorphisms at the
DNA level, to measure variability within or between eco-
logical populations, and to examine the genetic variabil-
ity in related species or their evolutionary relationships.
Additionally, to assess if our sequences were evolving
randomly (neutrally) or were under a selection process,
they were subjected to Tajima’s D test, in which positive
values indicate a decrease in population size or balan-
cing selection, while negative values suggest expansion
of the population or purifying selection [39].
Results
In the 192 samples analysed by microscopy, the follow-
ing parasites were identified: Blastocystis spp. (36.5%);
Entamoeba coli (33%); Endolimax nana (32%); Ent-
amoeba histolytica/E. dispar (15%); Hymenolepis nana
(10%); and Enterobius vermicularis (5.5%). Samples
belonging to 21 children exhibited Blastocystis single
infections (Table 1). In these cases, abdominal pain
was the main symptom described by all patients, and
the vacuolar form was observed in all samples. The
clinical and demographic data, parasite load, and
genotyping of both the 18S and PFOR genes are sum-
marized in Table 1.
For the 21 samples positive for Blastocystis, as well as for
the commercial strain ATCC-50754, all sequences were ob-
tained for both the 18S and PFOR genes (GenBank:
MH453913-MH453934 and MH507339-MH507360, re-
spectively). In this study, the Blastocystis STs were identified
as ST3 (43%), ST1 (38%), ST2 (14%) and ST7 (5%); only two
samples showed mixed ST infection with ST1 and ST2.
The Bayesian phylogenetic tree built for 18S corrobo-
rated the Blastocystis ST distribution (Fig. 1). In con-
trast, the tree generated for PFOR grouped parasite
species into different clades, and the main Blastocystis
clade did not show a clear distribution of STs. In two
clades (I and II), a mixture of STs was observed; in clade
III, six ST3 samples plus the ATCC commercial strain
were grouped (Fig. 2).
The genetic diversity indices obtained in the 18S analysis
showed similar values between ST1 and ST2, with π =
0.025 and θ = 0.036. Recall that π denotes the proportion
of nucleotide differences between possible pairs of se-
quences and θ is the proportion of nucleotide sites that
are expected to be polymorphic in any suitable sample
from this region of the genome. Remarkably, the values
for ST3 were almost 10-fold lower than other STs (π =
0.004 and θ = 0.005). In the same analysis of the PFOR
gene, a similar trend was found for clades I and II (π =
0.05 and θ = 0.05); whereas for clade III, the genetic diver-
sity indices values were π = 0.008 and θ = 0.009. Tajima’s
D test showed negative values for ST1-ST3 and clades
I-III for both the 18S and PFOR markers (Table 2).
Discussion
It has been argued that the 18S rRNA gene, which is
commonly used to distinguish Blastocystis STs, should
not be the marker of choice for discriminating between
strains within these STs [40, 41]. Poirier et al. [40]
reported that although Blastocystis has a high genetic
diversity, the 18S rRNA gene possesses at least 17 copies
that can be grouped into 6 clades. However, in ST7
comparisons with different strains, 4 of the 6 clades
showed high identity within the strains compared.
Markers other than the 18S rRNA gene have been used
to distinguish among Blastocystis strains or subtypes
[40–42]. Villalobos et al. [41] compared the internal
transcribed spacers (ITS) of ST1, ST2, ST3 and ST7 iden-
tified in human samples and found two variants of ST1.
Poirier et al. [40] reported that a single-copy subtyping
rDNA marker in the genome of mitochondria-like organ-
elles was capable of successfully subtyping 66 isolates of
Blastocystis ST1-ST10 from both humans and animals
and could also detect co-infections by different isolates of
the same ST. In the present study, we assessed the level of
genetic diversity in an ~871 bp region of the PFOR gene
of Blastocystis isolates from symptomatic carriers.
Blastocystis subtyping in samples provided by carriers
from the State of Mexico has not been previously docu-
mented. We found that ST3 and ST1 were the most fre-
quent subtypes, consistent with previous reports
describing children infected with Blastocystis from other
states in Mexico [41, 43]. Similarly, the values obtained
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in this study for nucleotide diversity (π) and haplotype
polymorphism (θ) for the 18S gene were in accordance
with previous studies of genetic diversity in Blastocystis
infections in children from other geographical regions of
Mexico [41, 43]. Interestingly, the π and θ values for
ST1 or ST2 were almost 10-fold higher than those for
ST3, indicating a high reduction of the variability within
and among sequences in this subtype. This result is con-
sistent with previous studies in which isolates of ST3
from patients with irritable bowel syndrome showed
lower genetic variability than those from asymptomatic
carriers [44]. A study focused on the genetic variability
and host specificity of Blastocystis spp. in wild howler
monkeys from two rainforest areas in the south-eastern
region of Mexico reported that ST1 exhibits a generalist
profile similar to a metapopulation, whereas ST2 existed
as a set of local populations [5]. Another study aimed to
determine the frequency and distribution of Blastocystis
subtypes in free-ranging Macaca fascicularis in Thailand
and showed that ST3 was the most common subtype de-
tected (36%), followed by ST2 and ST1 (24% and 17%,
respectively). However, some new subtype alleles were
also identified [45]. These reports suggest that the pres-
ence of different levels of cryptic host specificity in Blas-
tocystis may modify the genetic population structure of
this microorganism, including its levels of genetic
Fig. 1 Bayesian phylogenetic tree for the Blastocystis sequences obtained from children from Mexico using a fragment of the 18S rRNA gene. The
values of the nodes indicate posterior probabilities using 10,000,000 generations. The GenBank accession numbers of the reference sequences are
included; newly sequenced isolates are shown in different colours, ST1 is blue, ST2 is pink, ST3 is green and ST7 is red
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variability. Additionally, the negative values of Tajima’s
D test suggest a recent expansion process or an effect of
purifying selection in ST1-ST3 [39], strengthening the
action of other evolutionary forces in the epidemio-
logical landscape of Blastocystis. The mixed infections
with ST1 and ST2 identified in two samples in the
present study are in accordance with other studies re-
ported mixed infections of ST1 with other STs
(c.10%) [46, 47].
Regarding the phylogenetic tree for PFOR, sequences
that belonged to other parasites were grouped into sep-
arate clades as expected. The PFOR sequences that
belonged to Blastocystis were grouped into three clades.
In two of the clades, different STs were gathered without
a predominant ST; only one clade grouped seven sam-
ples of ST3 and also included the ATCC-50754 strain
(ST3). The presence of differences between the PFOR
and 18S trees is not surprising and is common when
phylogenetic inferences drawn from different genes are
compared [48]. Therefore, this initial analysis, although
indicating that the PFOR gene locus used in the present
study is not sensitive enough to differentiate subtypes,
suggests that the phylogeny of PFOR may provide infer-
ences about the function of the protein instead of the
Fig. 2 Bayesian phylogenetic tree for the PFOR Blastocystis sequences obtained from children from Mexico using a fragment of the PFOR gene.
The values of the nodes indicate posterior probabilities using 10,000,000 generations. The GenBank accession numbers of the reference sequences are
included; newly sequenced isolates are shown in different colours, ST1 is blue, ST2 is pink, ST3 is green and ST7 is red. Arrowheads point out isolates
with mixed infections of ST1 with ST2
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relationship of the group. On the other hand, it has
been argued that in some genomes of intestinal path-
ogens [49], including Blastocystis [50], PFOR is a
single-copy gene, and hence this marker may be sub-
jected to different selection pressures, according to
studies of multi- and single-copy genes [39]. In
addition, the results obtained could have been influ-
enced by other evolutionary processes, such as homo-
plasy [51], genetic hitchhiking [52] or simply the high
conservation of the analysed PFOR fragment, which
corresponds to a region inside the active site of the
protein. To clarify these factors, complete sequencing
of the PFOR gene should be performed. When com-
paring genetic resolution to the 18S gene, future
studies for of the PFOR gene and new genetic mo-
lecular markers must address mixed infections to
avoid problematic clustering, such as the clustering of
clades I and II observed in this study. 18S gene ana-
lysis has shown that this marker is sensitive enough
to resolve phylogenetic relationships, population
differentiation events and cryptic infections in Blasto-
cystis [41, 43, 53–55]. Finally, the knowledge of the
genetic variation within and between populations can
be applied to the epidemiology and the control of
parasites because these biological features influence
future evolutionary changes, genetic differentiation,
and speciation in many pathogens [5, 40, 41].
Conclusions
Although the fragment of the PFOR gene analysed in
present study did not allow discrimination between
Blastocystis STs, this marker grouped the samples in
three strongly-supported clades, suggesting that PFOR
may be under different selective pressures and
evolutionary histories than the 18S gene. Interestingly,
ST3 sequences showed lower variability with probable
purifying selection in both markers, meaning that
evolutionary forces are driving differential processes
among the Blastocystis STs. Finally, according to Poir-
ier et al. [56], the controversial role of Blastocystis
spp. as pathogens remains unclear. Thus, there is still
a need to conduct epidemiological studies focused on
distinguishing between strains within subtypes of this
genus.
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